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The Rab GTPase family regulates membrane domain
organization and vesicular transport pathways. Recent
studies indicate that one member of the family, Rab27a,
regulates transport of lysosome-related organelles in
specialized cells, such as melanosomes and lytic gran-
ules. Very little is known about the related isoform,
Rab27b. Here we used genetically modified mice to study
the involvement of the Rab27 proteins in mast cells,
which play key roles in allergic responses. Both Rab27a
and Rab27b isoforms are expressed in bone marrow-
derived mast cells (BMMC) and localize to secretory
granules. Nevertheless, secretory defects as measured
by b-hexosaminidase release in vitro and passive cutane-
ous anaphylaxis in vivo were found only in Rab27b and
double Rab27 knockout (KO) mice. Immunofluorescence
studies suggest that a subset of Rab27b and double
Rab27-deficient BMMCs exhibit mild clustering of gran-
ules. Quantitative analysis of live-cell time-lapse imaging
revealed that BMMCs derived from double Rab27 KO
mice showed almost 10-fold increase in granules exhibit-
ing fast movement (>1.5 mm/s), which could be disrupted
by nocodazole. These results suggest that Rab27 pro-
teins, particularly Rab27b, play a crucial role in mast cell
degranulation and that their action regulates the transi-
tion from microtubule to actin-based motility.
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Mast cells play central roles in allergic and T-helper
lymphocyte type 2-mediated immune responses (1). Mast
cell secretory granules store various inflammatory media-
tors including histamine and serotonin (2,3), and the
activation of the high-affinity immunoglobulin E (IgE)
receptor induces exocytosis of the granules, resulting in
inflammatory mediators release (4,5). The study of mast
cell secretion is thus of great relevance to therapeutically
modulate the activity of mast cells in the control of allergic
diseases, such as asthma.
The Rab family of Ras-like GTPases, which comprise more
than 60 members in mammalian cells, have been impli-
cated in regulated secretion (6). Rab3 proteins have been
studied for many years in neuronal and non-neuronal
regulated exocytotic events, but the precise mechanism
by which they operate remains controversial (7–9). More
recently, Rab27a has been implicated as a positive regula-
tor of regulated exocytosis in cytotoxic T lymphocytes
(10,11), pancreatic b-cells (12,13), neuroendocrine (14),
platelets (15) and prostate cells (16). Rab27a appears to
promote the switch between microtubule (MT)-based
organelle motility to actin-based motility by recruiting
myosin-interacting proteins, such as Melanophilin and
Myrip. These proteins in turn bind to unconventional
myosins such as Myosin Va, thereby promoting tethering
and movement along the actin cytoskeleton (17,18). Muta-
tionsinthehumanRAB27Agene causeGriscellisyndrome.
This disorder is characterized by partial albinism of the skin
and the hair associated with variable immunodeficiency,
and caused by motility defects in melanosomes and lytic
granules (18–21). Furthermore, Rab27a recruits effectors
of the synaptotagmin-like protein family (such as granuphi-
lin)and Munc13-4,whichmayactdownstreamofmyosinin
the docking of secretory vesicles with the plasma mem-
brane (22,23). The present evidence thus suggests that
Rab27aactsas a positive regulator of regulated secretionin
either conventional Golgi-derived granules in exocrine and
endocrine cells, or lysosome-related organelles in hemato-
poietic cells and melanocytes (19,21,24).
The mast cell secretory granules are considered lysosome-
related organelles as they share features with lysosomes,
such as containing lysosomal proteins (2,21). Rab3d was
proposed to be a regulator of mast cell secretory granule
exocytosis, because overexpression of Rab3d results in
a reduction of exocytosis in the model cell line, RBL-2H3
(25). However, mast cell secretion in Rab3d knockout (KO)
mice is unaffected (26). More recently, Rab27a and its
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exocytosis in RBL-2H3 cells (27,28).
The Rab27 subfamily consists of two isoforms sharing
71% amino acid sequence similarity, Rab27a and Rab27b
(29–31). Rab27a is widely expressed (24), whereas the ex-
pression of Rab27b is more restricted and detectable in
platelets, the pituitary gland and the digestive tract
(31–33). Very little is known about the function of Rab27b
other than being implicated as a positive regulator of exo-
crine gland exocytosis, namely, of zymogen granules in
pancreatic acinar cells (34) and amylase granules in parotid
acinar cells (35). We have recently generated a Rab27b KO
using a conditional Cre–loxP strategy, which enabled anal-
ysisofRab27functionsinspecializedcellsinvivoandinvitro
(36). We have shown that Rab27b KO and double Rab27a/
Rab27b KO mice exhibit significant hemorrhagic disease.
Platelets exhibited impaired in vitro aggregation properties,
and reduced number and secretion of dense granules (36).
In this paper, we describe mast cell function studies using
Rab27a KO, Rab27b KO and double KO mice. We show
surprisingly that despite expression of both isoforms, mast
cells exhibitopposite phenotypesinindividual KOs. Rab27b
appears to be the critical regulator of mast cell degranula-
tion by enabling peripheral actin-mediated retention of
granules near the plasma membrane prior to exocytosis.
Results
To determine the expression of Rab27 isoforms in mast
cells, we prepared interleukin-3 (IL-3) and stem cell factor-
dependent bone marrow-derived mast cells (BMMC) from
Rab27a KO or more precisely the naturally occurring ashen
(ash) strain, Rab27a
ash/ash, the recently created Rab27b
KO (Rab27b
 / )(36), the double Rab27 KO resulting from
the cross of these two strains (Rab27a
ash/ash; Rab27b
 / )
mice and respective heterozygote control littermates.
All BMMCs studied expressed both c-Kit and high-affinity
IgE receptor, markers that are characteristic of mature
BMMCs (data not shown). We detected expression of
both Rab27a and Rab27b proteins using isoform-specific
antibodies in wild-type BMMC lysates (Figure 1A). The
absence of reactivity in the respective KO lines confirms
thattheselinesindeedaredefectiveintheexpressionofthe
respective Rab27 isoform. We conclude that both Rab27a
and Rab27b proteins are expressed in BMMCs and that
their expression appears to be dispensable for the cytokine-
dependent emergence and differentiation of BMMC.
Next, we determined the intracellular localization of Rab27a
and Rab27b in BMMCs using immunofluorescence.
Immunostaining with the anti-Rab27b antibody indicated
that Rab27b exhibited a punctate vesicular staining pattern
throughout the cytoplasm, which overlapped with the
signalobtained fromthe anti-serotoninantibody (Figure 1B).
The Rab27a immunostaining pattern was more diffuse,
although some discrete punctate staining was also
Figure 1: Rab27 proteins in BMMCs. A) Bone marrow-derived
mast cells derivedfrom C57BL/6J wild-type, Rab27a KO(Rab27a
ash/ash),
Rab27b KO (Rab27b
 / ) and double KO (Rab27a
ash/ashRab27b
 / )
mice were subjected to immunoblot analysis as described under
Materials and Methods. B) Bone marrow-derived mast cells
derived from C57BL/6J wild-type mice were subjected to immu-
nofluorescence using anti-Rab27a, anti-Rab27b and anti-serotonin
antibodies. Representative single midsection images by confocal
microscopy are shown. Inserted images are enlarged. Bar, 10 mm.
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and to a lesser extent Rab27a are associated with seroto-
nin-containing mast cell secretory granules.
The presence of the Rab27 isoforms in BMMCs raised the
possibility that they could be controlling regulated secre-
tion in these cells and thus allergic responses in mice.
As a first test, we assessed the ability of the single and
double Rab27 KO lines to react against immune challenge
using the passive cutaneous anaphylaxis (PCA) response
because anaphylaxis mediated via high-affinity IgE recep-
tor is regarded predominantly as a mast cell-dependent
event (4). Mice were challenged intradermally with IgE or
saline in different locations of the dorsal dermis. After
sensitization, mice were injected intravenously with anti-
gen and dye, and PCA responses were measured after 1 h.
A marked reduction in PCA response was observed in
Rab27b and double KO mice (Figure 2B,C), despite the
presence of toluidine-positive cells in the dorsal dermis
(Figure S1). Surprisingly, the PCA response was enhanced
in Rab27a KO mice dermis (Figure 2A). These differences
were statistically significant (p < 0.05).
Theresults abovesuggested thatbothRab27aand Rab27b
expression was required for normal mast cell function,
presumably in the control of regulated secretion. Thus, we
next examined the effects of Rab27 KOs on antigen-
induced b-hexosaminidase release from BMMC in vitro.
These in vitro assays are rather variable from experiment
to experiment as they depend on the culture conditions
and can only be compared within experiments. Further-
more, the experiments shown are only qualitatively repre-
sentative as the magnitude of the response and the
differences observed also varied in independent experi-
ments. The antigen, dinitrophenyl (DNP)-BSA, induced
b-hexosaminidase release from BMMC cells sensitized
with anti-DNP IgE (Figure 3). In Rab27b KO BMMCs, we
observed a small decreased in the secretory response
(Figure 3B). In Rab27a KO BMMCs, we observed a small
increase in stimulated secretion (Figure 3A). Strikingly,
b-hexosaminidase release was more consistently reduced
in double Rab27 KO BMMCs (Figure 3C). The general
trend of these experiments was confirmed in antigen-
induced histamine release assays (data not shown). These
results were consistent with the PCA assay in vivo and
suggested that Rab27 proteins are key regulators of
antigen-induced secretion in mast cells.
Recent studies on Rab27a in melanocytes have led to the
proposal that the GTPase promotes the switch between
MT-based motility to actin-based motility of melanosomes
through the recruitment of Melanophilin and Myosin Va
(17,18). We therefore studied whether mast cell granule
localization was affected in the KO lines. Using immuno-
fluorescence of fixed cells, we observed scattered histamine-
positive granules (Figure 4) or serotonin-positive granules
(data not shown) throughout the cytoplasm in wild-type
and Rab27a KO-derived BMMCs. Conversely, in Rab27b
Figure 2: Passive cutaneous anaphylaxis assays in Rab27-
deficient mice. Rab27a
ash/ash (ash/ash) or heterozygote littermate
(ash/þ) mice (A), Rab27b
 /  ( / ) or heterozygote littermate
( /þ) mice (B), and Rab27a
ash/ashRab27b
 /  ( / ) or heterozygote
littermate ( /þ) mice (C) were subjected to PCA assays as
described under Materials and Methods. Data presented are the
mean with standard error of the mean of at least nine independent
experiments. *p < 0.05 (unpaired Student’s t-test).
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appeared more clustered (Figure 4) in a subset of BMMCs,
more specifically 32% of Rab27b KO (n ¼ 34) and 63% of
double KO (n ¼ 8) BMMCs, compared with no obvious
accumulation of granules in wild-type (n ¼ 55), Rab27a
þ/ash
(n ¼ 11), Rab27a
ash/ash (n ¼ 36), Rab27b
þ/  (n ¼ 21) and
Rab27a
þ/ash; Rab27b
þ/  (n ¼ 8) BMMCs.
To extend the above results and to examine granule
morphology in detail, we performed electron microscopy.
All BMMCs analyzed exhibited type I (multivesicular), type II
(multivesicular with dense core) and type III (dense core)
granules (2) without obvious differences between samples
(Figure 5A). Using immunoelectron microscopy, we
observed labeling for both Rab27a and Rab27b at the
limiting membrane of mast cell secretory granules of all
types and the relative distribution of both proteins
appeared similar (Figure 5B), although Rab27a staining
appeared more sparse.
We then studied mast cell secretory granule dynamics by
total internal reflection fluorescence (TIRF) microscopy.
Total internal reflection fluorescence microscopy allows
real-time imaging of fluorescence near the plasma mem-
brane. We used LysoTracker Red DND-99 as a marker for
secretory granules as we observed its concentration in
serotonin-positive granules (data not shown). In general,
we observed that the vast majority of granules in BMMCs
was stationary and a minority of granules was motile
(Figure 6; Movie S1). However, quantitative analysis re-
vealed significant differences between strains. Granules
exhibiting displacements over 1.5 mm were increased by
almost 10-fold in double KO BMMCs (and Rab27b KO
BMMCs, data not shown) as compared to double hetero-
zygote controls (Table 1; Movie S2). Conversely, the
percentage of motile granules defined as those with
displacements exceeding 0.5 mm and average velocity
exceeding 0.1 mm/s decreased in double KO BMMCs
(Table 1). Therefore, and given the large increase of fast-
moving granules (>1.5 mm/s) in double KO cells, the
twofold decrease in motile granules can be accounted by
a decrease in slow moving granules (<1.5 mm/s displace-
ment). We hypothesized that the fast movements
observed were attributable to MT-based motility; so we
treated cells with nocodazole, a MT-disrupting agent.
Consistently, nocodazole treatment inhibited the fast and
long-range movements of LysoTracker-labeled granules in
double KO BMMCs (Figure 6C; Movie S3). These results
suggest that the absence of Rab27 proteins leads to more
prominent MT-based motility of mast cell granules.
Figure 3: Antigen-induced b-hexosaminidase release in
BMMCs derived from Rab27-deficient mice. Bone marrow-
derived mast cells derived from Rab27a
ash/ash (ash/ash) or hetero-
zygote littermate (ash/þ) mice (A), Rab27b
 /  ( / ) or heterozy-
gote littermate ( /þ) mice (B) and Rab27a
ash/ashRab27b
 /  ( / )
or heterozygote littermate ( /þ) mice (C) were subjected to
b-hexosaminidase release assay as described under Materials
and Methods. After sensitization with anti-dinitrophenyl IgE,
the cells were stimulated with various concentration of DNP–BSA
for 20 min. Each point was determined in triplicate and presented
as mean with standard error of the mean. The experiments shown
are representative of at least three independent experiments.
*p < 0.05 (Mann–Whitney test).
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The present studies suggest a key role for Rab27 proteins
in the release of secretory granules in mast cells. Our data
indicate that simultaneous loss of both Rab27a and
Rab27b leads to a severe secretory defect in vitro and
poorreactivity in vivo.The granule dynamicsare affected in
double KO mice with a dramatic increase in fast-moving
granules, suggesting that the underlying defect could be
impaired transition between MT-based and actin-based
motility prior to exocytosis. Single KO of Rab27 isoforms
further suggests that Rab27b may be the key regulator in
mast cells given that the Rab27b phenotype mimics, albeit
less dramatically, that of the double KO.
The mode of action of Rab27a in melanocytes as a key
regulator of melanosome motility to recruit myosin motors
to mature melanosomes and thus induce their peripheral
retention has been intensively investigated (17,18). Our
present studies suggest that a similar mechanism may be
operating in mast cell granule dynamics. Rab27 isoforms
appear to be required for the transition from MTs to actin,
as revealed by our live-cell imaging and quantitative
analysis (Figure 6; Table 1; Movies S1, S2 and S3). Our
data suggest that MT-dependent secretory granule move-
ments are increased in double Rab27 KO mast cells,
presumably because of a disconnection between MT and
actin motor systems (Figure 6; Table 1). In Rab27b KO
mast cell, a similar but more subtle phenotype is observed,
both morphologically with some cells showing evidence of
perinuclear granule clustering (Figure 4) and functionally
with increased numbers of fast-moving granules (data not
shown). Therefore, our data is consistent with the involve-
ment of Rab27 proteins, particularly Rab27b in MT-actin
transition as previously established for Rab27a in skin
melanocytes. We speculate that Rab27 proteins recruit
a Rab-and-Myosin linker effector such as Melanophilin or
Myrip, which will then recruit an unconventional myosin.
Further studies should aim at identifying the Rab27 mo-
lecular partners in mast cell granule dynamics.
Mast cells represent a cell type where both Rab27a and
Rab27b are expressed, providing an opportunity to deter-
mine the relative contributions of each isoform and address
redundancy issues. Our studies suggest that when Rab27b
isabsent, thenRab27amay partially compensate for its loss
as a positive regulator of exocytosis, given that the secre-
tory defect in the double KO cells is more severe than in the
single Rab27b KO. The partial redundancy of the Rab27
isoforms was expected given our previous studies on the
Figure 4: Immunofluorescence analysis of
mast cell secretory granules in BMMCs
derived from Rab27-deficient mice. Bone
marrow-derived mast cells derived from
Rab27a
ash/þRab27b
 /þ (Double het),
Rab27a
ash/ash (Rab27a KO), Rab27b
 / 
(Rab27b KO) and Rab27a
ash/ashRab27b
 / 
(Double KO) were subjected to immunofluo-
rescence as described under Materials and
Methods, and stained with anti-histamine
(green) and anti-alpha-tubulin (red) antibodies.
Representative projected images using con-
focal microscopyas describedunderMaterials
and Methods are shown. Bar, 5 mm.
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transgenic heterologous expression of Rab27b in melano-
cytes could compensate for melanosome clustering and
coat color dilution in Rab27a KO (ash) mice (32). So far, only
a few cases of functional redundancy have been reported
for the Rab family, namely the requirement for simultan-
eous KO of all four Rab3 isoforms to achieve lethality (37)
and the redundant role of Rab38 and Rab32 in melanosome
biogenesis in skin melanocytes (38).
One surprising result obtained here was the increased
secretory responses in BMMCs derived from Rab27a
ash/ash
mice, raising the possibility that Rab27a and Rab27b
might have distinct roles in mast cell secretion. A possible
interpretation is that Rab27a performs an inhibitory func-
tion on regulated exocytosis in mast cells. Interestingly,
the secretory actions attributed to the related Rab3
proteins in the neuroendocrine PC12 cell line are also
inhibitory. Overexpression of any Rab3 isoform leads
Figure 5: Electron microscopy analy-
sis of BMMCs. A) Ultrathin sections of
epon-embedded BMMCs from the indi-
cated strains. Bar, 2 mm. B) Ultrathin
cryosections of BMMCs from EGFP-
Rab27a mice were double immunogold
labeled for Rab27b (PAG15) and Rab27a
(PAG10). Rab27a was detected with anti-
GFP. Labeling for both Rab27b (arrow-
heads) and Rab27a (arrows) could be
detected on the same granules Bar,
500 nm. Inset: example of a type II
granule containing an electron-dense
core and small internal vesicles. Bar,
250 nm. PM, plasma membrane.
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þþ-regulated exocytosis (39,40).
However, more detailed analysis revealed that the inhibi-
tory effect on regulated exocytosis is indirect and results
from an activation of constitutive exocytosis (40). There-
fore, one interesting possibility is that Rab27a may be
performing a similar action in mast cells. It is noteworthy
that Rab27 and Rab3 are able to interact with the same
effectors, such as Rabphilin, Granuphilin and Noc2 (23).
The findings presented here highlight some of the limita-
tions of studying cultured cell lines and conversely the
importance of studying primary cells in specialized sys-
tems of medical relevance. A previous study using RBL-
2H3 cells, a rat basophilic leukemia-derived cell line
commonly used as a model for mast cells implicated
Rab3d in regulated exocytosis (25). However, Rab3d KO
mice exhibit normal mast cell responses (26). Recent
studies suggested that Rab27a and its effector Munc13-
4 regulate exocytosis of secretory granules in the same
cell line (27,28). Our studies with primary cells suggest
instead that Rab27a performs an inhibitory role.
The identification of severely reduced mast cell responses
in vivo in the Rab27b KO mouse is the first report that
Rab27b contributes to allergic responses in mammals and
suggests that Rab27b may be a future drug target for
allergic diseases, such as asthma. In fact, the restricted
pattern of expression observed for Rab27b compared with
Rab27a further strengthens this possibility, suggesting
that interfering with Rab27b function may lead to rather
specific effects. Future studies should assess the thera-
peutic potential of interfering with Rab27b function.
Materials and Methods
Antibodies and reagents
The primary antibodies, mouse monoclonal anti-Rab27a antibody, rabbit
polyclonal anti-Rab27a antibody and rabbit polyclonal anti-Rab27b antibody
Table 1: Analysis of LysoTracker-positive granule movement in BMMCs
Genotype Average velocity (mm/s) Motile granules(%) Displacement (mm)
Number studied 0.5–1.0 1.0–1.5 >1.5
Double heterozygote 0.16   0.06 (n ¼ 408) 21.3 87 90.8% 8.0% 1.2%
Double KO 0.15   0.07 (n ¼ 521) 12.7 66 78.8% 10.6% 10.6%
Double KO þ nocodazole 0.05   0.03 2.7 ND ND ND ND
ND, not determined. The LysoTracker-positive granule movements were analyzed as described under Materials and Methods. Motile
granules are defined as ones with displacement exceeding 0.5 mm and average velocity exceeding 0.1 mm per second.
Figure 6: Secretory granule dyn-
amics in BMMCs. Bone marrow-
derived mast cells derived from
Rab27a
ash/þRab27b
 /þ (Double het)
(A), or Rab27a
ash/ashRab27b
 /  (Dou-
ble KO) mice in the absence (B) or
presence of nocodazole (C) were
labeled with LysoTracker Red DND-
99 and subjectedto TIRF microscopy
as described under Materials and
Methods. Arrowheads point to gran-
ules that remain still and arrows to
granules that exhibit fast movement
(>1.5 mm/s, see also Table 1).
Selected frames from time-lapse re-
cordings are presented. Bar, 2.5 mm.
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purchased from Biogenesis (Pool, UK). Rabbit anti-histamine antibody was
purchased from Research Diagnostics, Inc. (Flanders, NJ, USA). Mouse
anti-alpha-tubulin DM 1A antibody was purchased from Sigma (St Louis,
MO, USA). LysoTracker Red DND-99, Rhodamine-phalloidin, Alexa488- and
Alexa568-conjugated secondary antibodies were purchased from Mole-
cular Probes (Eugene, OR, USA). Horseradish peroxidase-linked antibodies
were purchased from DAKO (Glostrup, Denmark). DNP–BSA was prepared
as previously described (41).
Generation of Rab27b KO and double Rab27 KO mice
All mice were bred and maintained under UK project license PPL 70/6176 at
the Central Biomedical Services of Imperial College, London, UK. C57BL/6J
wild-type mice were purchased from B&K Universal Limited (Hull, UK).
ashen mice (C57BL/6J-ash/ash) (32) and EGFP-Rab27a transgenic mice (24)
were described previously. The generation of Rab27a KO mice and double
Rab27 KO was described elsewhere (36).
Primary mast cell culture
Bone marrow was obtained from the femur of mice of various genetic
background and cultured at 378C/5% CO2, in RPMI1640 (Invitrogen Life
Technologies, Paisley, UK) supplemented with 10% heat-inactivated fetal
calf serum, 55 mM 2-mercaptoethanol (2-ME) (Sigma-Aldrich, Poole, UK), 10
U/mL penicillin/streptomycin, 20 ng/mL recombinant murine IL-3 and 20 ng/
mL recombinant murine SCF (Peprotech, London, UK). The medium was
changed every 3–4 days and non-adherent cells were transferred to new
culture flasks. Bone marrow-derived mast cells appeared in the culture after
2 weeks and to determine the expression of high-affinity IgE receptor, cell
aliquots were first exposed to 2.4G2 rat anti-mouse FcgammaRII/RIII
antibody (BD Biosciences, San Diego, CA) and subsequently incubated
with SPE-7 mouse IgE (Sigma-Aldrich). Cell staining was performed with
fluorescein isothiocyanate-labeled monoclonal rat anti-mouse IgE antibody
(BD Biosciences) and phycoerythrin-labeled rat anti-c-Kit antibody (BD
Biosciences). As analyzed with a FACScalibur system (BD Biosciences),
>98% of the cells expressed both high-affinity IgE receptor and c-Kit after
4 weeks of differentiation. The experiments described below were all
performed with 4- to 9-week-old mast cells.
Immunoblotting
Bone marrow-derived mast cells were washed twice in PBS and solubilized
in 2  SDS sample buffer. Samples were loaded on polyacrylamide gels and
transferred to polyvinylidene difluoride membranes. After blocking, the
membranes were treated with the anti-Rab27a or anti-Rab27b antibodies
and immunoreactive proteins were detected using the enhanced chem-
iluminescence protocol (Amersham Biosciences, Piscataway, NJ, USA)
with horseradish peroxidase-linked secondary antibody (DAKO).
Passive cutaneous anaphylaxis
Mice were anesthetised and injected intradermally at two dorsal sites (left
and right flank) with 100 ng of murine monoclonal anti-DNP IgE (SPE-7;
Sigma) in 20 mL of saline. Twenty-four hours later, the mice were injected
intravenously with 100 mg of DNP–human serum albumin in 100 mL 0.5%
Evan’s blue dye (added to permit visual localization of increased vascular
permeability) in saline. Thirty minutes later, the mice were killed by
exsanguination under anesthesia, tissue sections around the intradermal
injection site excised and weighted, followed by extraction of extravasated
Evan’s blue dye by incubation of biopsies in 1 mL formamide at 558Cf o r
24 h and spectophotometric measurement of absorbance at 620 nm
(A620). Passive cutaneous anaphylaxis response was quantified by dye
extraction from IgE-injected and saline-injected skins. Data are expressed
as A620 of IgE-sensitized area minus A620 of saline-injected area per
weight of sample (g).
Histochemistry
Specimens of dorsal dermis were surgically excised and processed for
histochemistry using standard procedures (24). Paraffin sections (4 mm)
were stained with toluidine blue and eosin as counter staining.
Measurement of b-hexosaminidase release
Bone marrow-derived mast cells were washed twice in HEPES buffer
[140 mM NaCl, 5 mM KCl, 0.6 mM MgCl2,1m M CaCl2,1 0m M HEPES
(pH 7.4) and 5.5 mM glucose] and sensitized for 1 h by 2 mg/mL anti-DNP
mouse monoclonal IgE (Sigma-Aldrich). After sensitization, the cells were
washed twice with HEPES buffer, stimulated with DNP–BSA for 20 min
at 378C, and the reaction stopped by addition of ice-cold HEPES buffer.
After centrifugation (3000   g,4 8C), supernatants were collected and
supplemented with 10% Triton-X-100. Cell pellets were lysed with 10%
Triton-X-100 (in distilled water) and supplemented with ice-cold HEPES
buffer. Aliquots (100 mL) of supernatants or cell lysates were incubated
with 250 mL of 1.3 mg/mL p-nitrophenyl-N-acetyl-b-D-glucosamine (enzyme
substrate) dissolved in 0.1 M sodium citrate (pH 4.3) for 90 min at 378C.
Then 750 mLo fa0 . 2M glycine (pH 10.5) was added, and absorbance was
measured at 405 nm. Total enzyme activity was calculated as the sum of
supernatant and cell pellet activities. b-hexosaminidase release was ex-
pressed as the percentage of total enzyme content.
Assay of histamine release
Bone marrow-derived mast cells were washed twice in HEPES buffer and
sensitized for 1 h by 2 mg/mL anti-DNP mouse monoclonal IgE. After
sensitization, the cells were washed twice with HEPES buffer and
stimulated with DNP–BSA. After stimulation for 20 min at 378C, the
reaction was terminated by addition of ice-cold HEPES buffer. After
centrifugation (3000   g,4 8C), supernatants were harvested and perchloric
acid was added. The histamine content was measured by the o-phthalal-
dehyde fluorometric procedure (42). Briefly, the medium (0.6 mL) was
transferred to a tube containing 0.6 mL of 3% HClO4, and cells in each well
were used to measure histamine remaining in the cells by adding 1.2 mL
of 1.5% HClO4. To 0.5 mL of sample, a mixture of 100 mLo f
3 N KOH, 0.3 g of NaCl and 630 mLo fn-butanol was added. Then, the
samples were centrifuged at 1000   g for 3 min. The upper organic
phase (500 mL) was transferred to tubes containing 300 mL HCl (0.2 N) and
950 mL n-heptane. To the 250 mL of the lower aqueous phase, 100 mLo f
NaOH (1 N) was added. The histamine–OPT reaction was carried out by
incubation with 0.1 mL of OPT (0.05% in methanol) for 40 min on ice,
and terminated by addition of 100 mL citrate (2 M). The fluorescence of
the sample was measured at 450 nm emission excited at 360 nm with a
LS 50B (Perkin). Histamine release was expressed as the percentage of
total histamine content.
Confocal fluorescence microscopy
Bone marrow-derived mast cell from various genetic backgrounds were
plated on poly-lysine-coated cover glass. After 30 min, the cells were fixed
with 3.7% formaldehyde in PBS for 20 min at room temperature. The cells
were washed three times with PBS and were treated with 0.1% Triton-X-
100 in PBS for 15 min at room temperature. After blocking, the cells were
incubated with the first antibodies for 2 h at room temperature and were
washed three times with PBS, followed by incubation with the Alexa488- or
Alexa568-conjugated secondary antibody for 1 h at room temperature. The
cells were washed three times with PBS and were mounted on slide
glasses using DAKO mounting solution (DAKO). Fluorescence was visual-
ized through a Leica TCSNT confocal system in conjunction with Leica DM
IRBE. Z-axial sections were collected about 0.6-mm step and the projected
images were represented. Images were filtered using IMAGEJ and FFTJ and
DECONVOLUTIONJ PLUGIN (http://rsb.info.nih.gov/ij/).
Total internal reflection fluorescence microscopy
For labeling of mast cell secretory granules, BMMC was incubated with
200 nM LysoTracker Red DND-99 (Molecular Probes) for 30 min at
378C. After labeling, the cells were washed twice with HEPES buffer
plus 55 mM 2-ME. Fluorescence imaging was performed using Zeiss
Axiovert 200 inverted microscope modified for objective-type TIFR micro-
scopy (Till Photonics, Munich, Germany). An argon laser 514 nm line was
used to excite LysoTracker Red DND-99 through a 100  1.45 NA Zeiss
Planofluor objective. During observation, the cells were kept on MS2000
stage (Applied Scientific Instrumentation, Eugene, OR) equipped with
890 Traffic 2007; 8: 883–892
Mizuno et al.a Focht chamber system (FCS2, Biotechs, Butler, PA) at 308C. The images
were recorded using a PCO SensiCam CCD camera and analyzed using
IMAGEJ software. The images of each cell were recorded with 750 ms
exposure at 1-s intervals. The scale is 16 pixels per micrometer. The image
size was 236   236 pixels.
Quantitative analysis of granule dynamics
Total internal reflection fluorescence microscopy image sequences were
analyzed using VOLOCITY QUANTITATION software (Improvision, Coventry, UK).
Fluorescent particles were first selected by intensity threshold and size,
then smoothed by Gaussian filter and tracked using the shortest path
algorithm.
Electron microscopy
Bone marrow-derived mast cells on coverslips were fixed with 1.25%
glutaraldehyde in 0.1 M cacodylate buffer for 24 h. After several washes
with 0.1 M cacodylate buffer, the cells were postfixed with 2% OsO4,
dehydrated in ethanol and embedded in epon while on the coverslips.
Ultrathin sections were prepared and counterstained with uranyl acetate
and lead citrate before observation. For immunogold labeling, mast cells
were fixed with 2% (w/v) paraformaldehyde or with a mixture of 2% PFA
and 0.2% glutaraldehyde in 0.1 M phosphate buffer, pH 7.4. Bone marrow-
derived mast cell from EGFP-Rab27a mice were processed for ultra-
cryomicrotomy as described (2). Ultrathin sections were prepared with an
Ultracut FCS ultracryomicrotome (Leica, Wetzlar, Germany), and double
immunogold labeled with antibodies and protein A coupled to 5 or 10 nm
gold. Rab27b was detected with a specific antibody and Rab27a with an
anti-GFP antibody. Sections were observed and photographed under a
Philips CM120 Electron Microscope (FEI Company, Hillsboro, OR). Digital
acquisitions were made with a Keen View numeric camera (SIS, Klausdorf,
Germany).
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Supplementary Materials
Figure S1. Toluidine blue staining of skin sections. Dermal mast cells
were detected with toluidine blue staining in double heterozygote, Rab27a
KO, Rab27b KO and double KO mice back dermis. The sections were also
stained with eosin. The highly metachromatic cells are mast cells. Arrow-
head, mast cell. Bar, 200 mm.
Movies S1, S2, and S3. Secretory granule dynamics in BMMCs. Images
were captured every second. Playback speed is 7 frames per second.
Movie S1: Double Het; Movie S2: Double KO; Movie S3: Double KO with
nocadazole. See Figure 6 for more details.
Supplemental materials are available as part of the online article at http://
www.blackwell-synergy.com
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